Sonas Pharma is a preclinical biotechnology company focused on developing best-in-class, nextgeneration endocannabinoid system modulators for highburden metabolic and neurological disorders. By combining validated human biology with precision pharmacology, Sonas aims to bring forward differentiated small molecules designed to be both effective and safe.
Sonas Pharma: Venture Capital Funding History
Sonas Pharma
- Life Sciences
- Omagh, Northern Ireland
- sonaspharma.com
- Update Information
More venture news
- 26 Oct 2026

adsilicoadsilico unlocks a £10m Series A round led by PXN Ventures for virtual testing of implantable medical devices
Series ALife Sciences - 26 Oct 2026

imphatecimphatec raises a £1.5m seed round led by SynBioVen to develop customisable-dose implants for chronic conditions
SeedLife Sciences - 15 Oct 2026

OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences
